Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Current Protocols in Pharmacology|February 2, 2012
Overview of drug discovery and developmentMark A Ator, John P Mallamo, Michael Williams
Biochemistry|August 27, 2003
Pre-steady-state and steady-state kinetic analysis of E. coli class I ribonucleotide reductaseJie Ge, Guixue Yu, Mark A Ator, et al.
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Novel poly(ADP-ribose) polymerase-1 inhibitorsDerek Dunn, Jean Husten, Mark A Ator, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2006
Novel poly(ADP-ribose) polymerase-1 inhibitorsDerek Dunn, Jean Husten, Mark A Ator, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2012
Serendipity in discovery of proteasome inhibitorsDerek Dunn, Mohamed Iqbal, Jean Husten, et al.
Chemical Biology & Drug Design|May 18, 2013
Serendipitous discovery of a prodrug of a PARP-1 inhibitorDerek Dunn, Jean Husten, Lisa D Aimone, et al.
Chemical Biology & Drug Design|December 5, 2012
From an atypical wake-promoting agent to potent histamine-3 receptor inverse agonistsDerek Dunn, Rita Raddatz, Mark A Ator, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2005
Synthesis and structure-activity relationships of novel pyrrolocarbazole lactam analogs as potent and cell-permeable inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)Gregory J Wells, Ron Bihovsky, Robert L Hudkins, et al.
Bioorganic & Medicinal Chemistry|March 2, 2012
Proteasome inhibitors for cancer therapyMohamed Iqbal, Patricia A Messina McLaughlin, Derek Dunn, et al.
Assay and Drug Development Technologies|July 1, 2015
A Cellular Assay for Inhibitors of the Fatty Acid Biosynthetic Pathway Using Scintillating MicroplatesThao Ung, Jennifer L Mason, Ron G Robinson, et al.
Pageof 5